Skip to content

Effects of Multicomponent Training on Inflammation Parameters and Muscle Quality in Elderly Obese Woman

Effects of Multicomponent Training on Inflammation Parameters in Correlation With Muscle Quality and Function in Elderly Obese Woman

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05552677
Enrollment
38
Registered
2022-09-23
Start date
2022-08-01
Completion date
2022-12-30
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging Disorder, Obesity, Inflammation

Keywords

anabolic resistance, obesity, inflammation, physical exercise

Brief summary

Population aging worldwide has increased substantially in recent years. In order to prevent disabling diseases and improve the quality of life, it is necessary to understand the conditions related to the health of this specific population. One of the known alterations that occur in the body is the increased low-grade systemic inflammatory process, anabolic resistance, and muscle catabolism. These conditions can negatively interfere with muscle quality and functionality. However, the maintenance of the metabolic and physical functionality of muscle tissue can be preserved by performing physical exercises throughout life because of its anti-inflammatory mechanisms. In the present study, a multicomponent training program that combines aerobic, strength, balance, and flexibility capacities was used. The hypothesis is that performing this type of physical exercise will mitigate meta-inflammation and its negative effects, in addition to stimulating anabolic signals and reducing insulin resistance present in anabolic resistance, leading to improved quality and muscle functionality in elderly women with obesity.

Detailed description

Population aging worldwide has increased substantially in recent years. Therefore, it is necessary to know and understand the conditions related to the health of this specific population in order to prevent disabling diseases and improve the quality of life. One of the major concerns associated with the senescence process is the various physiological changes that can occur in the body. Body composition changes, bone loss, muscle catabolism, an increased low-grade systemic inflammatory process, and anabolic resistance all contribute to the development and/or worsening of several aging-related diseases. In particular, chronic low-grade inflammation, also known as meta-inflammation, can negatively interfere with muscle quality and functionality by reducing the muscle's ability to use energy substrates, amino acids, and perform protein synthesis. However, the maintenance of the metabolic and physical functionality of muscle tissue can be preserved by performing physical exercise throughout life because physical exercise can stimulate anti-inflammatory mechanisms. In the present study, a multicomponent training program will be used, which consists of training that combines aerobic, strength, balance, and flexibility capacities, and is capable of reducing inflammatory parameters and increasing physical and muscular capacities, resulting in a better quality of life and being thus attractive to this specific population. In view of this approach, the hypothesis is that performing this type of physical exercise is capable of mitigating meta-inflammation and its negative effects, in addition to stimulating anabolic signals and reducing insulin resistance present in anabolic resistance, leading to improved quality and muscle functionality in elderly women with obesity.

Interventions

Participants will perform a multicomponent training that explores strength, aerobic and balance capacities with load progression every 15 days. The sessions will last 60 minutes each, being held three times a week with a day of rest in between. The intervention will last 12 weeks

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Intervention model description

Randomized Clinical Trial

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* BMI between 30 and 40kg/m²;

Exclusion criteria

* alcoholics * smokers * diseases that prevents the practice of physical activity * medical impediment to the practice of physical exercise throughout the study * infectious diseases * coronary diseases * chronic kidney diseases * chronic use of corticosteroids * chronic use of immunomodulators * undergoing nutritional monitoring or weight loss treatment * score ≤13 for cognitive screening on the Mini-Mental State Examination (MMSE)

Design outcomes

Primary

MeasureTime frameDescription
Changes in inflamatory markers12 weeksEvaluate the inflamatory markers PCR, IL-1β, IL-6, IL-10, IL-15, TNF-α, NFκβ, NLRP3, myonectin, SIRT1, sTNFR1, IL-10, IL-13, adiponectin
Changes in muscle quality12 weeksEvaluate the quantity of intramuscular fat deposits trough ultrasound pre and post intervention

Secondary

MeasureTime frameDescription
Changes in metabolic parameters - insulin sensitivity12 weeksChanges in insulin sensitivity, estimated through HOMA-IR pre and post intervention
Changes in muscle remodeling peptides12 weeksChanges in PNPLA3 and PNP3 in blood samples in pre and post intervention
Body composition changes12 weeksChanges in fat-free mass and fat mass evaluated pre and post intervention by iDEXA
Changes in muscle function12 weeksEvaluate the muscle function trough the load test pre and post intervention
Changes in blood myostatin12 weeksChanges in blood myostatin levels pre and post intervention
Indirect calorimetry assessment12 weeksChanges in resting metabolic rate (RMR) evaluated pre and post intervention by indirect calorimetry
Changes in metabolic parameters - lipid profile12 weeksChanges in lipid profile (total cholesterol, HDL-c, LDL-c, triglycerides)samples in pre and post intervention
Changes of physical performance12 weeksPhysical performance changes, evaluated through physical tests.
Changes in metabolic parameters - fasting blood glucose12 weeksChanges in fasting blood glucose samples in pre and post intervention

Countries

Brazil

Contacts

Primary ContactSofia G Travieso, Specialist
sofia.travieso@usp.br16988084179

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026